Wednesday, May 24, 2023
10:00-11:00 am

Online
(Zoom link sent out prior to webinar)

FREE Registration

The U.S. National Science Foundation is a federal agency that supports research and education across all fields of science and engineering, currently with an $9.5 billion budget.

Through the merit review process, NSF funds the most innovative ideas in science and engineering. Notable NSF-supported advances include LASIK eye surgery, Doppler radar, the Internet, web browsers, bar codes, magnetic resonance imaging, inkjet printers, computer-aided design systems, tissue engineering, and other technology-based innovations that spur economic activity and improve the quality of life for all Americans.

NSF focuses on transforming scientific and engineering discoveries into products and services with commercial and societal impact through their SBIR/STTR funding. The deep technologies they fund show promise but their success hasn’t yet been validated. And, each year, $200+ million in research and development (R&D) funding is awarded to about 400 startups across the United States.

During this webinar, hear directly from SBIR/STTR Program Director Henry Ahn, who will cover:

  • NSF’s newly established Technology, Innovation and Partnerships (TIP) Directorate
  • Translational funding programs within TIP
  • In-depth details related to NSF’s SBIR/STTR Program
  • Special insights into the Biomedical Technologies topic within the SBIR/STTR Program

There will be time for live Q&A.

Presented by:

Henry Ahn

NSF SBIR/STTR Program Director
Henry Ahn joined the National Science Foundation in July 2016 as an SBIR/STTR Program Director. Prior to joining NSF, Henry managed seed/early stage investment programs for TEDCO for 12 years including Technology Commercialization Fund, TEDCO’s flagship seed funding program for technology-based companies in Maryland. During his time at TEDCO, Henry was actively involved with various entrepreneurs and entrepreneur support groups as a guest speaker, an advisory board member, a judge, a mentor, among others. Additionally, Henry was part of the licensing/supplier relations team at a biotechnology company called Upstate, where he successfully negotiated, licensed and commercialized approximately 190 biomedical research reagents from around the world. Henry has also done approximately five years of research, mostly in the field of immunology (including graduate work). Henry has an MBA from Rice University, an M.S. in biotechnology from the University of Tennessee, Knoxville and a B.S. in biomedical engineering from Boston University.

PLEASE NOTE – ONCE YOU REGISTER, YOU WILL BE DIRECTED TO A NEW SCREEN TO FILL OUT YOUR INFORMATION IN GOTOWEBINAR – YOU MUST DO THIS IN ORDER TO RECEIVE YOUR PERSONALIZED LINK TO ACCESS THE WEBINAR (please click on “Continue” after you register and it will take you to the new screen).

Skip to content